Meddig ellenorizzük a szérum-hCG-szintet molaterhesség után?

Translated title of the contribution: How long to control serum hCG titers after hydatidiform mole?

Bátorfi József, Cseh Imre, Feltmate Colleen M., Szigetvári Iván, Berkowitz Ross S., Fülöp Vilmos

Research output: Contribution to journalArticle

Abstract

In hydatidiform mole the pathologic structure and function of placenta lead to abnormal pregnancy without viable fetus. Some of these diseases may develop into malignant trophoblast tumors with local uterine invasion or far metastases. Malignant trophoblast diseases can be treated exceedingly because of their extremely good response for chemotherapy. A long time follow up of patients is very important after uterine evacuation. Regular control of serum β-hCG titers accurately indicates the state of the disease, the recovery, the remission, and increasing titers can evidence the relapse, respectively. Current follow up protocols suggest weekly serum β-hCG controls until undetectable titers are reached, then monthly checks for several months to verify the remission of the disease. According to the analysis of 550 patients' data, our workgroup did not find any case, where the continuously decreasing hCG titers indicated relapse of molar pregnancy after reaching undetectable levels, during monthly controls. Developing into malignant trophoblastic tumors after hCG titers fell to zero seems to be extremely rare. Although prolonged monthly checks are advisable for the patients, it may be appropriate to reconsider the duration of currently suggested follow up. Perhaps - if further analyses of data report similar experiences - a shorter follow up protocol may be sufficient after hydatidiform mole.

Original languageHungarian
Pages (from-to)163-166
Number of pages4
JournalOrvoskepzes
Volume78
Issue number4
Publication statusPublished - Dec 1 2003

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

József, B., Imre, C., Colleen M., F., Iván, S., Ross S., B., & Vilmos, F. (2003). Meddig ellenorizzük a szérum-hCG-szintet molaterhesség után? Orvoskepzes, 78(4), 163-166.